Long-Term Treatment with Sarilumab Plus Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs): Pooled Safety and Efficacy with over 4 Years' Treatment Genovese, M. C., van Hoogstraten, H., St John, G., Dong, Q., Jose Gomez-Reino, J., Maldonado-Cocco, J. A., Carlos Salazar, J., Huizinga, T. J., Burmester, G. R. WILEY. 2018

View details for Web of Science ID 000447268904242